Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many proteins in biology exist in more than one form. Examples include ion channels that control electrical activity in the body, metabolic enzymes, and proteins called transcription factors that help control gene expression. In immune cells, one family of transcription factors, the NFAT family, is important in cell differentiation and activation. NFATs control the expression of genes that produce signaling molecules that help co-ordinate the activities of different immune cells and defective NFAT activation is linked to a range of human diseases. Immune cells express several different NFATs, and it has proved difficult to control selectively the activity of each protein.

Professor Anant Parekh’s group in DPAG have discovered how different NFAT proteins are controlled in cells. Their new findings, published in this month’s Molecular Cell (58, 232-243), demonstrate that different patterns of signal recruit different NFAT proteins. Their results open up the possibility for drugs aimed at targeting one NFAT protein and not another, allowing for selective therapeutic control of an immune response.

Read more (Department of Physiology, Anatomy and Genetics website)

Similar stories

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.